mitindomide has been researched along with etoposide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allan, WP; Creighton, AM; Hasinoff, BB; Kozlowska, H; Thampatty, P; Yalowich, JC | 1 |
1 other study(ies) available for mitindomide and etoposide
Article | Year |
---|---|
Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Diketopiperazines; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Indoles; Isoindoles; Piperazines; Razoxane; Topoisomerase II Inhibitors | 1997 |